Honda, Y., Imajo, K., Kato, T., Kessoku, T., Ogawa, Y., Tomeno, W., . . . Nakajima, A. (2016). The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice. PLoS One.
Citação norma ChicagoHonda, Yasushi, et al. "The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect On Nonalcoholic Steatohepatitis in Mice." PLoS One 2016.
Citação norma MLAHonda, Yasushi, et al. "The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect On Nonalcoholic Steatohepatitis in Mice." PLoS One 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.